Europlasma S.A. (EPA:ALEUP)
France · Delayed Price · Currency is EUR 0.0002
0.00 (0.00%)
Nov 10, 2026, 3:52 PM CET
Europlasma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 59.76 | 70.42 | 42.45 | 15.41 | 14.52 | 9.8 |
Other Revenue | -7.49 | - | 0.37 | 0.04 | 0.37 | 1.43 |
| 52.27 | 70.42 | 42.82 | 15.44 | 14.89 | 11.24 | |
Revenue Growth | -18.06% | 64.47% | 177.25% | 3.71% | 32.51% | 70.64% |
Cost of Revenue | 31.14 | 40.22 | 20.18 | 11.7 | 9.18 | 6.17 |
Gross Profit | 21.13 | 30.2 | 22.63 | 3.75 | 5.71 | 5.07 |
Selling, General & Admin | 56.97 | 54.5 | 34.23 | 17.89 | 17.57 | 14.54 |
Other Operating Expenses | -4.55 | -4.4 | 1.97 | -1.33 | -0.04 | -0.2 |
Operating Expenses | 61.67 | 59.72 | 48.93 | 23.39 | 21.71 | 16.55 |
Operating Income | -40.54 | -29.52 | -26.29 | -19.64 | -16 | -11.48 |
Interest Expense | - | -8.34 | -3.14 | -3.58 | -5.66 | -6.27 |
Interest & Investment Income | 0.41 | 0.06 | 0.01 | 0.04 | 0.01 | 0 |
Earnings From Equity Investments | - | - | - | - | - | -0.45 |
Currency Exchange Gain (Loss) | 0.11 | 0.11 | 0.09 | - | -0.01 | 0.07 |
Other Non Operating Income (Expenses) | -1.17 | -0.98 | 6.2 | 7.16 | -1.99 | 0.12 |
EBT Excluding Unusual Items | -41.19 | -38.67 | -23.14 | -16.02 | -23.65 | -18.02 |
Asset Writedown | - | - | - | -0.18 | -0.46 | -0.1 |
Other Unusual Items | 0.56 | 0.07 | 4.47 | 1.1 | 8.12 | 5.14 |
Pretax Income | -40.63 | -38.61 | -18.66 | -15.1 | -15.99 | -12.97 |
Income Tax Expense | -1.69 | -0.68 | -2.75 | -0.36 | -0.24 | -0.3 |
Earnings From Continuing Operations | -38.95 | -37.93 | -15.91 | -14.75 | -15.75 | -12.68 |
Minority Interest in Earnings | 2.79 | 2.34 | 0.62 | 0 | -0.17 | 0 |
Net Income | -36.15 | -35.59 | -15.29 | -14.74 | -15.92 | -12.67 |
Net Income to Common | -36.15 | -35.59 | -15.29 | -14.74 | -15.92 | -12.67 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 724 | 941 | - | - | - | - |
Shares Outstanding (Diluted) | 724 | 941 | - | - | - | - |
Shares Change | 108.51% | - | - | - | - | - |
EPS (Basic) | -0.05 | -0.04 | - | - | - | - |
EPS (Diluted) | -0.05 | -0.04 | - | - | - | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -16.34 | -20.35 | -12.4 | -11.7 | -8.04 | -23.63 |
Free Cash Flow Per Share | -0.02 | -0.02 | - | - | - | - |
Gross Margin | 40.42% | 42.89% | 52.86% | 24.26% | 38.36% | 45.12% |
Operating Margin | -77.56% | -41.91% | -61.41% | -127.18% | -107.45% | -102.18% |
Profit Margin | -69.16% | -50.54% | -35.71% | -95.47% | -106.94% | -112.78% |
Free Cash Flow Margin | -31.27% | -28.90% | -28.96% | -75.76% | -54.01% | -210.32% |
EBITDA | -32.54 | -21.66 | -14.65 | -14.82 | -10.96 | -10.2 |
EBITDA Margin | -62.25% | -30.75% | -34.22% | -95.95% | -73.59% | -90.74% |
D&A For EBITDA | 8 | 7.86 | 11.64 | 4.82 | 5.04 | 1.29 |
EBIT | -40.54 | -29.52 | -26.29 | -19.64 | -16 | -11.48 |
EBIT Margin | -77.56% | -41.91% | -61.41% | -127.18% | -107.45% | -102.18% |